SCHEMBL2316992

SCHEMBL2316992

CC(=O)/C=C/C1=CC(C)(C)COc2ccc(F)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 4/20 0.39
GAA P10253 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
PGR P06401 2/20 0.36
NOTUM Q6P988 1/20 0.34
FABP6 P51161 1/20 0.34
KIF11 P52732 1/20 0.34
NR3C2 P08235 1/20 0.33
AR P10275 1/20 0.33
MAPT P10636 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TGM2 P21980 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2316995 1.00 ALDH1A1 (0.39) ALDH1A1KDM4EGAAL3MBTL1ESR1
SCHEMBL3597034 0.88 RXRA (0.43) ALDH1A1KDM4EGAAL3MBTL1NOTUM
SCHEMBL3597027 0.88 RXRA (0.43) ALDH1A1KDM4EGAAL3MBTL1NOTUM
SCHEMBL2315354 0.86 MAPT (0.35) ALDH1A1KDM4EGAAL3MBTL1PGR
SCHEMBL2315349 0.86 MAPT (0.35) ALDH1A1KDM4EGAAL3MBTL1PGR
SCHEMBL2315971 0.85 AR (0.35) PGRNOTUMARMAPTMAOA
SCHEMBL2315966 0.85 AR (0.35) PGRNOTUMARMAPTMAOA
SCHEMBL2314398 0.85 APP (0.34) ALDH1A1KDM4EGAAL3MBTL1PGR
SCHEMBL2314394 0.85 APP (0.34) ALDH1A1KDM4EGAAL3MBTL1PGR
SCHEMBL2314361 0.85 CCNB2 (0.36) ALDH1A1KDM4ENOTUMMAOBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP claimed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP claimed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO claimed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP claimed
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP disclosed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP disclosed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO disclosed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP disclosed